Adocia: New phase Ib start with BC lisproBUY, Fair Value EUR113 (+52%)
A new phase Ib study is starting with BC lispro in type II diabetes. Lilly, whose Diabetes franchise has strengthened a lot with Trulicity and Jardiance recently, shows strong commitment to BC lispro. It is still the prime asset of Adocia. We still expect a phase III start in H1 2016.
For more information, please contact email@example.com